Walmart Agrees to $50M Settlement

What Happened

The Justice Department and DEA announced in August 2026 a $50 million settlement with Walmart Inc. to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act. The complaint, filed December 22, 2020 in the District of Delaware, alleged that since June 26, 2013 Walmart's compliance team and pharmacists filled prescriptions from known pill mill prescribers. Walmart also entered a memorandum of agreement with DEA requiring a reporting hotline, monitoring of dispensing patterns and a process to evaluate suspected prescribers. The release states there has been no determination of liability.

“a $50 million settlement with Walmart Inc. (Walmart) to resolve allegations that Walmart pharmacies illegally filled thousands of invalid prescriptions”
U.S. Department of Justice / U.S. Attorney's Office press release, Aug 28, 2026

Related Guidance

15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
Investigation Playbook — How to investigate suspected diversion inside an organization.

Sources

U.S. Department of Justice / U.S. Attorney's Office press release, Aug 28, 2026

Case at a Glance

Setting: Walmart Inc. pharmacies, including members of its compliance team and its pharmacists
Drug: Opioids and other controlled substances
Method: Allegedly filled invalid prescriptions, including those from known pill mill prescribers and those with red flags such as dangerous opioid combinations and repeated early fills
Status: Agreed to $50 million settlement (August 2026); memorandum of agreement with DEA; no determination of liability

Source: U.S. Department of Justice

What this case shows

Where this record connects to the site's working material. Links are chosen from the case's setting, drug and method fields.

Share: LinkedIn X Facebook

Last reviewed: September 2026 · Educational content, not legal advice.

About the author

DivertGuard is built and maintained by Alex Rodriguez, MHIIM, CPhT (also known as Jesus Rodriguez) — a drug diversion prevention program manager with more than a decade in pharmacy practice, including direct responsibility for a health-system controlled substance diversion prevention program.

Conference presentations

2025 — The Rounding Revolution: A High-Tech Approach to Diversion Prevention (with Emily Spiceland, PharmD)
2024 — No Pill Left Behind: Strategies for Comprehensive Drug Accountability (with Eric Andrews)
2022 — Ready for My Close Up! Implementing, Maintaining, and Expanding Drug Diversion Prevention Cameras (with Jeremy Quinn, Shawn Young, and John Bailey)

Other professional engagement

Faculty, ASHP Drug Diversion Certificate
Speaker, Health Care Compliance Association (HCCA)
Published author, Pharmacy Purchasing & Products

Credentials

Doctorate candidate — Doctor of Health Informatics (DHI), Rutgers University, School of Health Professions; research on health data analytics and the prediction of cognitive decline
MHIIM — master's in health informatics, University of Tennessee Health Science Center (2019–2021)
CPhT — Certified Pharmacy Technician, with 10+ years of pharmacy practice across retail, hospice, compounding, home-health, and hospital settings

The assessment items, weighting, and case registry behind this site come from that operational background — building and running a diversion prevention program, not from vendor marketing. Every tool here is free, requires no signup, and is based on published regulatory and professional standards (DEA, Joint Commission, ASHP, CDC).

Full author bio and credentials →

Would your controls have caught this?

The free self-assessment scores your own controls: 8 sections, 63 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment

Related Resources

Diversion Settlements & Fines

Settlements, civil penalties and criminal fines paid by hospitals and pharmacies in documented drug diversion cases, with the amount, year and primary source for each

Penalty Outcomes in the Case Records

Counts of the outcomes the registry records state: prison, probation, fines, licence actions and restitution, with stated sentence lengths by band and by drug class

Registry Insights: Sentences, Fines, States and Outcomes

Sentence lengths, fines and restitution, cases per 100,000 pharmacists by state, and plea and licence outcomes, each counted from the case records with its n, plus charts of cases by year, state and drug class

Walmart Agrees to $50M Settlement Over Unlawful Opioid Fills